| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
group | 0.100 | None | 0.897 | 58 | 0 | 1995 | 2020 | |||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
group | 0.100 | None | 0.970 | 33 | 0 | 1998 | 2014 | |||||||||
|
MT-CO2 pseudogene 12 | 0.368 | 0.962 |
|
group | 0.100 | None | 0.968 | 31 | 0 | 1998 | 2014 | |||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
group | 0.100 | None | 1.000 | 19 | 0 | 2009 | 2020 | |||||||||
|
microRNA 205 | 0.482 | 0.846 |
|
group | 0.100 | None | 1.000 | 12 | 0 | 2008 | 2017 | |||||||||
|
small cell cancer of the lung | 0.612 | 0.577 |
|
group | 0.100 | None | 1.000 | 11 | 0 | 2002 | 2019 | |||||||||
|
H3 histone pseudogene 28 | 0.553 | 0.692 |
|
group | 0.100 | None | 0.800 | 10 | 0 | 2012 | 2020 | |||||||||
|
H3 histone pseudogene 23 | 0.443 | 0.769 |
|
group | 0.090 | None | 0.889 | 9 | 0 | 1998 | 2017 | |||||||||
|
long intergenic non-protein coding RNA 1194 | 0.470 | 0.769 |
|
group | 0.080 | None | 1.000 | 8 | 0 | 1999 | 2019 | |||||||||
|
microRNA 375 | 0.476 | 0.769 |
|
group | 0.070 | None | 1.000 | 7 | 0 | 2009 | 2019 | |||||||||
|
microRNA 126 | 0.447 | 0.846 |
|
group | 0.060 | None | 1.000 | 6 | 0 | 2014 | 2019 | |||||||||
|
microRNA 31 | 0.471 | 0.769 |
|
group | 0.060 | None | 1.000 | 6 | 0 | 2013 | 2018 | |||||||||
|
Pulmonary disease, chronic obstructive, severe early-onset | 0.456 | 0.885 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2014 | 2019 | |||||||||
|
microRNA 27a | 0.466 | 0.846 |
|
group | 0.060 | None | 1.000 | 5 | 0 | 2009 | 2018 | |||||||||
|
PPP1R2C family member C | 0.478 | 0.846 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2002 | 2020 | |||||||||
|
cancer/testis antigen 1B | 0.507 | 0.731 |
|
group | 0.040 | None | 0.750 | 4 | 0 | 2013 | 2017 | |||||||||
|
cancer/testis antigen 1A | 0.508 | 0.731 |
|
group | 0.040 | None | 0.750 | 4 | 0 | 2013 | 2017 | |||||||||
|
Adolescent idiopathic scoliosis | 0.593 | 0.615 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 2014 | 2017 | |||||||||
|
hypertrichosis 2 (generalized, congenital) | 0.392 | 0.808 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 2004 | 2009 | |||||||||
|
microRNA 22 | 0.496 | 0.808 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 2015 | 2019 | |||||||||
|
microRNA 34a | 0.421 | 0.846 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 2012 | 2015 | |||||||||
|
cytochrome c oxidase subunit I | 0.441 | 0.885 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 2000 | 2018 | |||||||||
|
platelet and endothelial cell adhesion molecule 1 | 0.426 | 0.846 |
|
group | 0.040 | None | 0.750 | 4 | 0 | 1996 | 2020 | |||||||||
|
suppression of anchorage independence 1 | 0.560 | 0.615 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 1995 | 1999 | |||||||||
|
hyperpigmentation, progressive, 1 | 0.686 | 0.346 |
|
group | 0.040 | None | 0.750 | 4 | 0 | 2002 | 2006 |